Neurobiology of attention deficit/hyperactivity disorder;Neurobiologie du trouble déficit de I'attention/ hyperactivité

Medecine/Sciences

Volumn 26, Issue 5, 2010, Pages 487-496

  Purper Ouakil, Diane ^a,b   Lepagnol Bestel, Aude Marie ^a   Grosbellet, Edith ^d   Gorwood, Philip ^a   Simonneau, Michel ^c  

^a INSERM   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c CENTRE DE PSYCHIATRIE ET NEUROSCIENCES   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77952983859     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2010265487     Document Type: Review

References (46)

1. 1. Polanczyk G, de Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007; 164: 942-948 (Pubitemid 46972911)
2. Spencer TJ, Biederman J, Mick E. Attention-deficit/hyperactivity disorder diagnosis, lifespan, comorbidities, and neurobiology. Ambul Pediatr 2007; 7 (suppl 1) : 73-81.
3. 3. Mannuzza S, Klein RG, Bessler A, et al. Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry 1998; 155: 493-498 (Pubitemid 28207444)
4. Galéra C, Melchior M, Chastang JF, et af. Childhood and adolescent hyperactivity-inattention symptoms and academic achievement 8 years later the GAZEL youth study. Psychol Med 2009; 39: 1895-1906
5. rd. Lifetime criminality among boys with attention deficit hyperactivity disorden a prospective follow-up study into adulthood using official arrest records. Psychiatr Res 2008 ; 160: 237-246
6. Faraone SV, Doyle AE. The nature and heritability of attention-deficit/ hyperactivity disorder. Child Adolesc Psychiatr Clin North Am 2001; 10:299-316, viii-ix.
7. 7. Langley K, Rice F, van den Bree MB, Thapar A. Maternal smoking during pregnancy as an environmental risk factor for attention deficit hyperactivity disorder behaviour. Minerva Pediatr 2005; 57: 359-371 (Pubitemid 44251940)
8. 8. Thapar A, Fowler T, Rice F, et al. Maternal smoking during pregnancy and attention deficit hyperactivity disorder symptoms in offspring. Am J Psychiatry 2003; 160: 1985-9.
9. Mill J, Petronis A. Pre- and peri-natal environmental risks for attentiondeficit hyperactivity disorder (ADHD): the potential role of epigenetic processes in mediating susceptibility. J Child Psychol Psychiatry 2008 ; 49:1020-1030
10. Sonuga-Barke EJ. Causal models of attention-deficit/hyperactivity disorder from common simple deficits to multiple developmental pathways. Biol Psychiatry 2005; 57: 1231-1238
11. Rommelse NN, Arias-Vásquez A, Altink ME, et al. Neuropsychological endophenotype approach to genome-wide linkage analysis identifies susceptibility loci for ADHD on 2q21.1 and 13q12.11. Am J Hum Genet 2008: 83: 99-105.
12. Volkow ND, Wang GJ, Fowler JS, Ding YS. Imaging the effects of methylphemdate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperoctivity disorder. Biol Psychiatry 2005; 57: 1410-1415
13. Sagvolden T, Johansen EB, Aase H, Russell VA. A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav Brain Sci 2005 ; 28: 397-419 ; discussion 419-468
14. 14. Easton N, Shah YB, Marshall FH, et al. Guanfacine produces differential effects in frontal cortex compared with striatum: assessed by phMRI BOLD contrast Psychopharmacology (Berl) 2006 ; 189: 369-385 (Pubitemid 44773700)
15. Brennan AR, Arnsten AF. Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function. Ann Ny Acad Sci 2008; 1129: 236-245
16. Gonon F. The dopaminergic hypothesis of attention-deficit/hyperactivity disorder needs re-examining. Irenas Neurosa 2009; 32: 2-8.
17. 17. Van der Kooij MA, Glennon JC. Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder. Neurosa Biobehav Rev 2007; 31: 597-618. (Pubitemid 46527883)
18. DasBanerjee T, Middleton FA, Berger DF, et al. A comparison of molecular alterations in environmental and genetic rat models of ADHD: a pilot study. Am J Med Genet B Neuropsychiatr Genet 2008; 147B : 1554-1563
19. Zhou K, Chen W, Buitelaar J, et al. Genetic heterogeneity in ADHD: DAT1 gene only affects probands without CD. Am J Med Genet 2008; 147B : 1481-1487
20. Neale B, Faraone S. Perspective on the genetics of attention deficit/ hyperactivity disorder. Am J Med Genet 2008; 147B : 1334-1336
21. Zhou K, Dempfle A, Arcos-Burgos M, et al. Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am J Med Genet 2008; 147B : 1392-1398
22. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature 2009; 461: 747-753
23. 23. Tsankova N, Renthal W, Kumar A, Nestler EJ. Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 2007; 8: 355-367 (Pubitemid 46652469)
24. 24. Mill J, Richards S, Knight J, et al. Haplotype analysis of SNAP-25 suggests a role in the aetiology of ADHD. Mol Psychiatry 2004; 9: 801-810 (Pubitemid 39107969)
25. Winsberg BG, Comings DE. Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. J Am Acad Child Adolesc Psychiatry 1999 ; 38: 1474-1477
26. Purper-Ouakil D, Wohl M, Orejarena S, et al. Pharmacogenetics of methylphenidate response in attention deficit/hyperactivity disorder: Association with the dopamine transporter gene (SLC6A3). Am J Med Genet Neuropsychiatr Genet 2008 ; 147B : 1425-1430
27. 27. McGough J, McCracken J, Swanson J, et al. Pharmacogenetics of methylphenidate response in preschoolers with ADHD J Am Acad Child Adolesc Psychiatry 2006; 45: 1314-1322 (Pubitemid 44665448)
28. 28. Seeger G, Schloss P, Schmidt MH. Functional polymorphism within the promotor of the serotonin transporter gene is associated with severe hyperkinetic disorders. Mol Psychiatry 2001; 6: 235-238 (Pubitemid 32187877)
29. 29. Neuman RJ, Lobos E, Reich W, et al. Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype. Biol Psychiatry 2007; 61: 1320-1328 (Pubitemid 46855768)
30. Todd RD, Neuman RJ. Gene-environment interactions in the development of combined type ADHD: evidence for a synapse-based model. Am J Med Genet Neuropsychiatr Genet 2007; 144B : 971-975
31. Bush G. Attention-deficit/hyperactivity disorder and attention networks. Neuropsychopharmacology 2010; 35: 278-300.
32. 32. Valera EM, Faraone SV, Murray KE, Seidman LJ. Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol Psychiatry 2007; 61: 1361-1369 (Pubitemid 46855763)
33. Shaw P, Eckstrand K, Sharp W, et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci USA 2007; 104: 19649-19654
34. 34. Dickstein SG, Bannon K, Castellanos FX, Milham MP. The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis.; Child Psychol Psychiatry 2006; 47: 1051-1062 (Pubitemid 44642434)
35. 35. Puloyelis Y, Menta MA, Kuntsi J, Asherson P. Functional MRI in ADHD: a systematic literature review. Exp Rev Neurother 2007; 7: 1337-1356 (Pubitemid 350012723)
36. 36. Sagvolden T. Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosa Biobehav Rev 2000 ; 24: 31-39 (Pubitemid 30026144)
37. Heyser CJ, Wilson MC, Gold LH. Coloboma hyperactive mutant exhibits delayed neurobehavioral developmental milestones. Brain Res Dev Brain Res 1995; 89: 264-269
38. 38. Gainetdinov RR, Caron MG. An animal model of attention deficit hyperactivity disorder. Mol Med Today 2000; 6: 43-44 (Pubitemid 30010236)
39. -/- mice. Behav Genet 2008 ; 38: 503-514
40. 40. Moon J, Beaudin AE, Verosky S, et al. Attentional dysfunction, impulsivity, and resistance to change in a mouse model of fragile X syndrome. Behav Neurosa 2006; 120: 1367-1379 (Pubitemid 46058712)
41. 41. Li D, Sham PC, Owen MJ, He L. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Mol Genet 2006 ; 15: 2276-2284 (Pubitemid 43994869)
42. Gizer IR, Ficks C, Waldman ID. Candidate gene studies of ADHD: a meta-analytic review. Hum Genet 2009; 126: 51-90.
43. 43. Yang B, Chan RC, Jing J, et al. A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3'-UTR of dopamine transporter gene and attention deficit hyperactivity disorder. Am J Med Genet Neuropsychiatr Genet 2007; 144B : 541-550 (Pubitemid 46983166)
44. 44. Smoller JW, Biederman J, Arbeitman L, et al. Association between the 5HT1B receptor gene (HTR1B) and the inattentive subtype of ADHD. Biol Psychiatry 2006 ; 59: 460-467 (Pubitemid 43289227)
45. 45. Faraone SV, Perils RH, Doyle AE, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005; 57: 1313-1323 (Pubitemid 40798551)
46. Mick E, Faraone SV. Genetics of attention deficit hyperactivity disorder. Child Adolesc Psychiatr Clin North Am 2008.